<p>TORONTO, Canada — The United States Food and Drug Administration has issued a warning letter to a company that appears to sell products containing human fecal matter without approval from the a
</p><p>This type of therapy should only be used in the context of an authorized clinical trial, or to treat patients with recurrent Clostridium difficile, also known as C.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: